PhRMA Funnels Millions to Groups Fighting Drug Pricing Reforms
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
Health
Trump’s Top Campaign Aide Is a Tobacco Lobbyist
Susie Wiles of Mercury Public Affairs, a senior advisor to Trump's campaign, is lobbying for Swisher as it fights a proposal meant to reduce youth smoking.
Novo Nordisk Lobbies Up to Win Medicare Coverage of Its Weight Loss Drugs
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
STOCK TICKER: Blumenthal’s Wife Invests in Biotech Hedge Fund as He Chairs Panel Overseeing Drug Prices
As a consumer protection subcommittee chairman, Blumenthal has focused on the role pharmaceutical benefit managers play in driving up the cost of drugs.
Drug Lobby Revenues Skyrocket During Covid Pandemic
Lobbying giant PhRMA reported revenues of more than $600 million in 2021, a new record for the group.
With Abortion Access at Stake, These Companies Donated to Anti-Choice Georgia Republican AG Chris Carr
Carr squeaked out a re-election win over a Democratic rival who pledged that she would not enforce Georgia's "heartbeat law" abortion ban.